SK287922B6 - Method for preparing a 7-qunolinyl-3,5-dihydroxyhept-6-enoate - Google Patents
Method for preparing a 7-qunolinyl-3,5-dihydroxyhept-6-enoate Download PDFInfo
- Publication number
- SK287922B6 SK287922B6 SK1237-2003A SK12372003A SK287922B6 SK 287922 B6 SK287922 B6 SK 287922B6 SK 12372003 A SK12372003 A SK 12372003A SK 287922 B6 SK287922 B6 SK 287922B6
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- compound
- hydrogen peroxide
- reaction
- dihydroxyhept
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 24
- 150000001639 boron compounds Chemical class 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 12
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 10
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 10
- 125000003118 aryl group Chemical group 0.000 claims abstract description 5
- 239000011541 reaction mixture Substances 0.000 claims abstract description 5
- 239000007864 aqueous solution Substances 0.000 claims abstract 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 7
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- 150000007529 inorganic bases Chemical class 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000007810 chemical reaction solvent Substances 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- NEHKARMWCGDCNP-UHFFFAOYSA-N 3,5-dihydroxy-7-quinolin-2-ylhept-6-enoic acid Chemical compound C1=CC=CC2=NC(C=CC(O)CC(O)CC(O)=O)=CC=C21 NEHKARMWCGDCNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 125000003944 tolyl group Chemical group 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 21
- 239000002904 solvent Substances 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 12
- 239000012044 organic layer Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 238000006722 reduction reaction Methods 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- MAUQAXOHCVNUMX-BUHFOSPRSA-N ethyl (e)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound CCOC(=O)CC(O)CC(O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 MAUQAXOHCVNUMX-BUHFOSPRSA-N 0.000 description 9
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 8
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- VGYFMXBACGZSIL-VAWYXSNFSA-M (e)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound [O-]C(=O)CC(O)CC(O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 VGYFMXBACGZSIL-VAWYXSNFSA-M 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- -1 dibutylmethoxyborane Chemical compound 0.000 description 5
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 229910000085 borane Inorganic materials 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- FESAXEDIWWXCNG-UHFFFAOYSA-N diethyl(methoxy)borane Chemical compound CCB(CC)OC FESAXEDIWWXCNG-UHFFFAOYSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910052796 boron Inorganic materials 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 125000006165 cyclic alkyl group Chemical group 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 150000000185 1,3-diols Chemical class 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- BVBBICKLCGKYME-UHFFFAOYSA-N ethoxy(diethyl)borane Chemical compound CCOB(CC)CC BVBBICKLCGKYME-UHFFFAOYSA-N 0.000 description 1
- DPBQVLWVWXLRGW-BUHFOSPRSA-N ethyl (e)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-5-hydroxy-3-oxohept-6-enoate Chemical compound CCOC(=O)CC(=O)CC(O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 DPBQVLWVWXLRGW-BUHFOSPRSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000004296 sodium metabisulphite Substances 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CMHHITPYCHHOGT-UHFFFAOYSA-N tributylborane Chemical compound CCCCB(CCCC)CCCC CMHHITPYCHHOGT-UHFFFAOYSA-N 0.000 description 1
- LALRXNPLTWZJIJ-UHFFFAOYSA-N triethylborane Chemical compound CCB(CC)CC LALRXNPLTWZJIJ-UHFFFAOYSA-N 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001106820 | 2001-04-05 | ||
| PCT/JP2002/002779 WO2002081451A1 (fr) | 2001-04-05 | 2002-03-22 | Procede relatif a l'elaboration de 7-quinolinyl-3,5-dihydroxyhept-6-enoate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK12372003A3 SK12372003A3 (sk) | 2004-04-06 |
| SK287922B6 true SK287922B6 (sk) | 2012-04-03 |
Family
ID=18959261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1237-2003A SK287922B6 (sk) | 2001-04-05 | 2002-03-22 | Method for preparing a 7-qunolinyl-3,5-dihydroxyhept-6-enoate |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7038056B2 (ko) |
| EP (1) | EP1375485B1 (ko) |
| JP (1) | JP4380160B2 (ko) |
| KR (1) | KR100838135B1 (ko) |
| CN (1) | CN1241914C (ko) |
| AT (1) | ATE506349T1 (ko) |
| AU (1) | AU2002241271B2 (ko) |
| CA (1) | CA2442713C (ko) |
| CZ (1) | CZ20032633A3 (ko) |
| DE (1) | DE60239793D1 (ko) |
| HU (1) | HUP0401401A3 (ko) |
| IL (2) | IL158151A0 (ko) |
| MX (1) | MXPA03009095A (ko) |
| NO (1) | NO326089B1 (ko) |
| NZ (1) | NZ528149A (ko) |
| RU (1) | RU2260001C2 (ko) |
| SK (1) | SK287922B6 (ko) |
| TW (1) | TWI317356B (ko) |
| UA (1) | UA76984C2 (ko) |
| WO (1) | WO2002081451A1 (ko) |
| ZA (1) | ZA200307704B (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100445267C (zh) * | 2005-10-21 | 2008-12-24 | 上海医药工业研究院 | 4-(4-氟-苯基)-3-羟甲基-2-环丙基-喹啉的制备方法 |
| KR101160152B1 (ko) * | 2009-02-24 | 2012-06-27 | 한미사이언스 주식회사 | 스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| US4645854A (en) * | 1985-04-25 | 1987-02-24 | Merck & Co., Inc. | Process for preparing HMG-CoA reductase inhibitors with a 3,5-dihydroxypentanoate subunit |
| CA1282425C (en) | 1984-06-04 | 1991-04-02 | Meyer Sletzinger | Process for preparing hmg-coa reductase inhibitors with a 3,5-dihydroxypentanoate subunit |
| CA1336714C (en) | 1987-08-20 | 1995-08-15 | Yoshihiro Fujikawa | Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis |
| JP2569746B2 (ja) * | 1987-08-20 | 1997-01-08 | 日産化学工業株式会社 | キノリン系メバロノラクトン類 |
| US5753675A (en) * | 1989-03-03 | 1998-05-19 | Novartis Pharmaceuticals Corporation | Quinoline analogs of mevalonolactone and derivatives thereof |
| JP3528186B2 (ja) * | 1991-06-24 | 2004-05-17 | 日産化学工業株式会社 | 光学活性キノリンメバロン酸のジアステレオマー塩 |
| JP3554036B2 (ja) * | 1994-09-06 | 2004-08-11 | 宇部興産株式会社 | 光学活性な７−置換キノリル−３，５−ジヒドロキシ−ヘプト−６−エン酸エステル誘導体の製造方法 |
| JP2001526256A (ja) * | 1997-12-19 | 2001-12-18 | ワーナー−ランバート・エクスポート・リミテッド | １，３−ジオールの合成方法 |
| JP4236463B2 (ja) * | 2000-10-13 | 2009-03-11 | ダイセル化学工業株式会社 | 光学活性な（３ｒ，５ｓ，６ｅ）−７−［２−シクロプロピル−４−（４−フルオロフェニル）キノリン−３−イル］−３，５−ジヒドロキシ−６−ヘプテン酸エチルの製造方法 |
| EP1365029A4 (en) * | 2001-02-02 | 2009-07-29 | Mitsubishi Chem Corp | PROCESS FOR PRODUCING ACID ESTERS (3R, 5S) - (E) -7- 2-CYCLOPROPYL-4- (4-FLUOROPHENYL) -QUINOLIN-3-YL-3,5-DIHYDROXYHEPT-6-ENIC |
-
2002
- 2002-03-22 RU RU2003132440/04A patent/RU2260001C2/ru not_active IP Right Cessation
- 2002-03-22 US US10/473,132 patent/US7038056B2/en not_active Expired - Fee Related
- 2002-03-22 KR KR1020037012898A patent/KR100838135B1/ko not_active IP Right Cessation
- 2002-03-22 CA CA2442713A patent/CA2442713C/en not_active Expired - Fee Related
- 2002-03-22 CZ CZ20032633A patent/CZ20032633A3/cs unknown
- 2002-03-22 UA UA2003098877A patent/UA76984C2/uk unknown
- 2002-03-22 WO PCT/JP2002/002779 patent/WO2002081451A1/ja active IP Right Grant
- 2002-03-22 CN CNB028078454A patent/CN1241914C/zh not_active Expired - Fee Related
- 2002-03-22 IL IL15815102A patent/IL158151A0/xx unknown
- 2002-03-22 NZ NZ528149A patent/NZ528149A/en not_active IP Right Cessation
- 2002-03-22 JP JP2002579439A patent/JP4380160B2/ja not_active Expired - Lifetime
- 2002-03-22 DE DE60239793T patent/DE60239793D1/de not_active Expired - Lifetime
- 2002-03-22 AU AU2002241271A patent/AU2002241271B2/en not_active Ceased
- 2002-03-22 EP EP02707129A patent/EP1375485B1/en not_active Expired - Lifetime
- 2002-03-22 MX MXPA03009095A patent/MXPA03009095A/es active IP Right Grant
- 2002-03-22 HU HU0401401A patent/HUP0401401A3/hu unknown
- 2002-03-22 AT AT02707129T patent/ATE506349T1/de not_active IP Right Cessation
- 2002-03-22 SK SK1237-2003A patent/SK287922B6/sk not_active IP Right Cessation
- 2002-04-02 TW TW091106610A patent/TWI317356B/zh active
-
2003
- 2003-09-29 IL IL158151A patent/IL158151A/en not_active IP Right Cessation
- 2003-10-02 ZA ZA200307704A patent/ZA200307704B/xx unknown
- 2003-10-03 NO NO20034438A patent/NO326089B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL158151A (en) | 2009-09-22 |
| SK12372003A3 (sk) | 2004-04-06 |
| UA76984C2 (en) | 2006-10-16 |
| TWI317356B (ko) | 2009-11-21 |
| ZA200307704B (en) | 2004-10-04 |
| EP1375485A1 (en) | 2004-01-02 |
| NO20034438L (no) | 2003-10-03 |
| JP4380160B2 (ja) | 2009-12-09 |
| RU2003132440A (ru) | 2005-01-10 |
| KR20030086342A (ko) | 2003-11-07 |
| CN1241914C (zh) | 2006-02-15 |
| CZ20032633A3 (cs) | 2003-12-17 |
| KR100838135B1 (ko) | 2008-06-13 |
| WO2002081451A1 (fr) | 2002-10-17 |
| CA2442713C (en) | 2010-05-18 |
| MXPA03009095A (es) | 2004-02-12 |
| NO326089B1 (no) | 2008-09-15 |
| US7038056B2 (en) | 2006-05-02 |
| US20050014947A1 (en) | 2005-01-20 |
| NZ528149A (en) | 2005-05-27 |
| HUP0401401A3 (en) | 2012-05-02 |
| EP1375485A4 (en) | 2005-03-23 |
| IL158151A0 (en) | 2004-03-28 |
| DE60239793D1 (de) | 2011-06-01 |
| ATE506349T1 (de) | 2011-05-15 |
| EP1375485B1 (en) | 2011-04-20 |
| CN1500079A (zh) | 2004-05-26 |
| RU2260001C2 (ru) | 2005-09-10 |
| NO20034438D0 (no) | 2003-10-03 |
| JPWO2002081451A1 (ja) | 2004-07-29 |
| AU2002241271B2 (en) | 2007-01-25 |
| CA2442713A1 (en) | 2002-10-17 |
| HUP0401401A2 (hu) | 2004-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102171199A (zh) | 制备2-烷基-3-芳酰基-5-硝基-苯并呋喃类的方法 | |
| AU2010209650B2 (en) | Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof | |
| KR960000758B1 (ko) | 광학적 활성 히드록시벤질아민 유도체 및 그의 제조방법 | |
| US10053420B2 (en) | Processes for the preparation of compounds, such as 3-arylbutanals, useful in the synthesis of medetomidine | |
| EP0990647B1 (en) | Process for producing quinolone derivatives | |
| SK287922B6 (sk) | Method for preparing a 7-qunolinyl-3,5-dihydroxyhept-6-enoate | |
| D'hooghe et al. | Ring Opening Reactions of 1-arenesulfonyl-2-(bromomethyl) aziridines | |
| KR100541786B1 (ko) | (3-알콕시페닐)마그네슘 클로라이드를 사용한 알콜의 제조방법 | |
| EP1807401B1 (en) | Process for the preparation of phenyl 2-pyrimidinyl ketones and their novel intermediates | |
| Buchlovič et al. | Allenyloxime—a new source of heterocyclizations to stable cyclic nitrones | |
| SK284852B6 (sk) | Spôsob výroby pyridín-2,3-dikarboxylátových zlúčenín a ich medziprodukty | |
| GB1585625A (en) | Process for the production of 2-alkyl or 2 - cycloalkyl - 4 - methyl - 6 - hydroxypyrimidines | |
| JPWO2002081451A6 (ja) | ７−キノリニル−３，５−ジヒドロキシヘプト−６−エン酸エステルの製造法 | |
| Abulikemu et al. | Improved synthesis of perfluorooctylpropyl amine | |
| AU2022264993A1 (en) | Preparation method for pyrrole amide compound | |
| JP3918468B2 (ja) | ３，３−ビス（アルコキシカルボニル−メチルチオ）プロピオニトリル及びその製造方法 | |
| JPH035466A (ja) | フェノキシエチルアミノピリミジン誘導体の製造法 | |
| Schmitt et al. | (E)-ethyl β-formylacrylate dimethylhydrazone methiodide: A reactive and convenient precursor of (E)-ethylβ-formylacrylate | |
| SK284184B6 (sk) | Spôsob prípravy (+/-)3-(3,4-dichlórfenyl)-2-dimetylamino-2- metylpropan-1-olu čiže ceriklamínu (INN) | |
| EP3950659A1 (en) | Method for preparing 2-arylmalonic acid derivative, intermediate, and application thereof | |
| JPS61233676A (ja) | ２−メチル−３−カルボン酸アミドキノキサリン−１，４−ジ−ｎ−オキシドの新規な製造法 | |
| JPH07138255A (ja) | ２−チオレノン類の製造法 | |
| JP2002069062A (ja) | ３−ヒドロキシイソオキサゾールを製造する方法 | |
| SK282702B6 (sk) | Spôsob výroby tramadolu a jeho solí |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20140322 |